Sinopep-Allsino Biopharmaceutical Co. Ltd. A - Asset Resilience Ratio

Latest as of March 2026: 2.30%

Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has an Asset Resilience Ratio of 2.30% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 688076 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Liquid Assets

CN¥156.90 Million

≈ $22.96 Million USD Cash + Short-term Investments

Total Assets

CN¥6.82 Billion

≈ $997.38 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2020–2025)

This chart shows how Sinopep-Allsino Biopharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. See Sinopep-Allsino Biopharmaceutical Co. Lt net asset quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Sinopep-Allsino Biopharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Sinopep-Allsino Biopharmaceutical Co. Lt (688076) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥156.90 Million	2.3%
Total Liquid Assets	CN¥156.90 Million	2.30%

Asset Resilience Insights

Limited Liquidity: Sinopep-Allsino Biopharmaceutical Co. Ltd. A maintains only 2.30% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Sinopep-Allsino Biopharmaceutical Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Sinopep-Allsino Biopharmaceutical Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	10.93%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Wuhan Hvsen Biotechnology Co Ltd SHE:300871	Biotechnology	6.52%
Shenzhen Weiguang Biological Products Co Ltd SHE:002880	Biotechnology	5.52%
AbClon Inc KQ:174900	Biotechnology	14.74%

Annual Asset Resilience Ratio for Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2020–2025)

The table below shows the annual Asset Resilience Ratio data for Sinopep-Allsino Biopharmaceutical Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	1.72%	CN¥116.00 Million ≈ $16.97 Million	CN¥6.74 Billion ≈ $986.32 Million	-2.38pp
2024-12-31	4.10%	CN¥208.00 Million ≈ $30.44 Million	CN¥5.08 Billion ≈ $743.07 Million	+2.39pp
2022-12-31	1.71%	CN¥43.01 Million ≈ $6.29 Million	CN¥2.52 Billion ≈ $369.09 Million	-2.39pp
2021-12-31	4.10%	CN¥87.13 Million ≈ $12.75 Million	CN¥2.13 Billion ≈ $311.23 Million	-1.64pp
2020-12-31	5.73%	CN¥80.00 Million ≈ $11.71 Million	CN¥1.40 Billion ≈ $204.22 Million	--

pp = percentage points

About Sinopep-Allsino Biopharmaceutical Co. Ltd. A

SHG:688076 China Biotechnology

Market Cap

$1.27 Billion

CN¥8.67 Billion CNY

Market Cap Rank

#8039 Global

#1923 in China

Share Price

CN¥27.43

Change (1 day)

+1.07%

52-Week Range

CN¥27.14 - CN¥49.31

All Time High

CN¥90.43